Samuels Louis, Arce Anastasia, Agunbiade Samiat, Raws Suzanne, Parsikia Afshin
Department of Surgery, Division of Cardiac Surgery, Jefferson-Einstein Medical Center Philadelphia, Philadelphia, PA, USA.
J Cardiothorac Surg. 2025 Jan 27;20(1):101. doi: 10.1186/s13019-025-03347-4.
End-Stage Renal Disease (ESRD) is an independent risk factor in outcomes for traditional coronary artery bypass grafting (TRAD-CAB) utilizing aortic cross-clamping and cardioplegic arrest. In order to determine if Beating-Heart CABG (BH-CABG) techniques offer benefit in patients with ESRD, an analysis of the Society of Thoracic Surgeons (STS) predicted risk versus the actual outcomes was performed.
Between March 2017 - October 2023, all ESRD patients underwent BH-CABG by a single surgeon at a single institution. Patients were kept normothermic, ventilation was maintained, and intra-coronary shunts with flow-probe graft assessment were utilized during the procedure. The STS predicted risk calculator was used to compare outcomes with actual results.
There were 55 patients- 37 men and 18 women with a mean age of 61.5 years (41-77 years). Co-medical conditions consisted of the following: HTN (100%), DM (85%), Pulmonary HTN (49%), PVD (45%), CVD with CVA (18%), and COPD (9%). Fifty-one patients underwent Pump-Assisted Direct Coronary Artery Bypass Grafting (PADCAB) and four underwent Off-Pump CABG (OP-CAB). There were 16 Elective, 35 Urgent, and 4 Emergent cases. Case presentation included: 24 NSTEMI, 4 STEMI, 6 Unstable Angina, 7 CHF, 1 Cardiac Arrest, and 13 with a positive exercise stress test (EST) for renal transplant screening. The mean EF was 47% (range: 15-75%). The mean number of grafts was 2.4 (1-4) and CPB time was 78 min (34-128 min) for the PAD-CAB group. Nine of the thirteen patients (69%) listed for kidney transplant underwent the transplant, one of whom was a combined liver-kidney. There was 1 hospital mortality (1.8%) compared to a predicted 6.2%. There was 1 stroke (1.8%) compared to a predicted 3.3%. There was 1 prolonged ventilation (1.8%) compared to a predicted 20.2%. There were no return to OR and no sternal wound infections. Prolonged Lengths of Stay occurred in 3 patients (5.5%) compared to a predicted 16.9%. One-year mortality occurred in 8 patients (14.5%). The observed-to-expected outcomes was < 1 in all categories.
The BH-CABG appears to demonstrate superior outcomes compared to the STS predicted risk for CABG. The Beating-Heart technique may offer advantages by avoidance of aortic cross-clamping and cardioplegia, maintenance of normothermia and ventilation, as well as preservation of coronary blood flow during construction of bypass grafting.
终末期肾病(ESRD)是传统冠状动脉搭桥术(TRAD-CAB)采用主动脉交叉钳夹和心脏停搏时影响手术结果的独立危险因素。为了确定不停跳冠状动脉搭桥术(BH-CABG)技术是否对ESRD患者有益,对胸外科医师协会(STS)预测风险与实际结果进行了分析。
2017年3月至2023年10月期间,所有ESRD患者均由单一机构的一名外科医生进行BH-CABG手术。术中患者保持正常体温,维持通气,并使用带流量探头的冠状动脉分流器评估移植物。使用STS预测风险计算器将结果与实际结果进行比较。
共55例患者,其中男性37例,女性18例,平均年龄61.5岁(41 - 77岁)。合并疾病包括:高血压(100%)、糖尿病(85%)、肺动脉高压(49%)、外周血管疾病(45%)、伴有脑血管意外的心血管疾病(18%)和慢性阻塞性肺疾病(9%)。51例患者接受了泵辅助直接冠状动脉搭桥术(PADCAB),4例接受了非体外循环冠状动脉搭桥术(OP-CAB)。其中择期手术16例,急诊手术35例,紧急手术4例。病例表现包括:24例非ST段抬高型心肌梗死,4例ST段抬高型心肌梗死,6例不稳定型心绞痛,7例心力衰竭,1例心脏骤停,13例运动负荷试验(EST)阳性用于肾移植筛查。平均射血分数为47%(范围:15 - 75%)。PAD-CAB组平均移植血管数为2.4(1 - 4)支,体外循环时间为78分钟(34 - 128分钟)。13例等待肾移植的患者中有9例(69%)接受了移植,其中1例为肝肾联合移植。实际医院死亡率为1.8%,而预测死亡率为6.2%。实际卒中发生率为1.8%,而预测发生率为3.3%。实际长时间通气发生率为1.8%,而预测发生率为20.2%。无再次手术及胸骨伤口感染发生。实际住院时间延长的患者有3例(5.5%),而预测发生率为16.9%。1年死亡率为8例(14.5%)。所有类别中观察到的与预期的结果比值均<1。
与STS预测的CABG风险相比,BH-CABG似乎显示出更好的结果。不停跳技术可能通过避免主动脉交叉钳夹和心脏停搏、维持正常体温和通气以及在搭桥血管构建过程中保持冠状动脉血流而具有优势。